Is this what has been driving the stock? It's certainly been driving my shares of NVAX higher.as well ... I'm certainly one happy investor -but I don't see any mentions of bird flu on the board.....the stock has been up on heavy volume while news pertaining to CERS has been relatively quiet.... thoughts?
I think the fact of the German/Austrian contracts and their impact on 3rd/4th quarter revenues is what has us here in the high $4 range. The fact that the FDA has proposed an approval path for FFP/PLT without a new expensive P3 bodes well in 2014/2015......FDA approval will be HUGE especially the PLT part maybe in 2015. In the back ground is the P3 for RBC in EU and if that were to be successful this time....... well I cant even imagine the stock price. Also it is puzzling why the 2nd-3rd world has shown little interest? Maybe Australia will get on board at some point?